Sanochemia Pharmazeutika AG operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Sanochemia Pharmazeutika AG with three other
pharmaceutical manufacturers in Europe:
sales of 170.23 million Romanian Leu [US$42.97 million]
Eurobio Scientific SA
(42.67 million Euro [US$50.15 million]
of which 100%
was Genetic R&D), and
Malin Corporation Plc
based in Ireland
(41.90 million Euro [US$49.24 million]
During the year ended September of 2017, sales at
Sanochemia Pharmazeutika AG were 41.36 million Euro (US$48.61 million).
increase of 5.2%
versus 2016, when the company's sales were 39.30 million Euro.
This was the fifth consecutive year of sales increases at Sanochemia Pharmazeutika AG
(and since 2012, sales have increased a total of 37%).
Sales of Human Pharmaceuticals saw an increase
6.4% in 2017, from
24.96 million Euro to 26.55 million Euro.
Not all segments of Sanochemia Pharmazeutika AG experienced an increase in sales in 2017:
sales of R&d fell 28.0% to 430,000.00 Euro.
(However, this segment's sales were only a very small portion of the company's overall sales).